Infertility Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F. Sforza 28, 20122, Milan, Italy.
Division of Human Reproduction, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
J Assist Reprod Genet. 2023 Mar;40(3):599-607. doi: 10.1007/s10815-022-02700-z. Epub 2023 Jan 13.
A reduced oocyte competence has been claimed as one of the factors underlying infertility in women with endometriosis. This idea has justified the hypothesis that intracytoplasmic sperm injection (ICSI), rather than conventional IVF (c-IVF), may overcome oocyte impairment and ensure better assisted reproduction technology (ART) outcomes; however, data from the literature are controversial. Thus, the aim of this study was to compare ART success rates following (c-IVF) between women with and without endometriosis in the presence of normozoospermic partners.
This is a retrospective, matched case-control study of 314 patients who underwent c-IVF cycles between January 2014 and December 2020. Women with endometriosis were matched in a 1:1 ratio with patients undergoing ART for other indications, considering age (± 6 months), number of oocytes retrieved (± 1), and study period. The main outcome measures included total fertilization failure, fertilization rate, embryo quality, cumulative clinical pregnancy, and live birth rates.
The fertilization rate and the proportion of women with total fertilization failure did not differ between women with and without endometriosis. Similarly, all other embryological variables did not also differ, except for the number of top-quality cleavage stage embryos which was higher in the endometriosis group. Cumulative clinical pregnancy and live birth rates were similar between women with and without endometriosis.
A diagnosis of endometriosis does not negatively affect the performance of c-IVF; thus, c-IVF can be efficiently used in women affected, unless a male factor is also involved. This issue holds clinical relevance to help operators on their insemination technique decision-making.
有人认为,卵母细胞功能降低是子宫内膜异位症女性不孕的原因之一。这一观点使人们假设,胞浆内单精子注射(ICSI)而非常规体外受精(c-IVF)可能克服卵母细胞损伤,确保更好的辅助生殖技术(ART)结局;然而,文献中的数据存在争议。因此,本研究旨在比较有和无子宫内膜异位症的正常精子伴侣的患者接受 c-IVF 后的 ART 成功率。
这是一项回顾性、1:1 配对病例对照研究,纳入了 314 名于 2014 年 1 月至 2020 年 12 月期间接受 c-IVF 周期的患者。根据年龄(±6 个月)、获卵数(±1)和研究期间,将患有子宫内膜异位症的患者与接受 ART 治疗其他适应症的患者进行 1:1 配对。主要结局指标包括总受精失败率、受精率、胚胎质量、累积临床妊娠率和活产率。
子宫内膜异位症患者与无子宫内膜异位症患者的受精率和总受精失败率无差异。同样,除优质卵裂期胚胎数量较高外,所有其他胚胎学变量也无差异。子宫内膜异位症患者和无子宫内膜异位症患者的累积临床妊娠率和活产率相似。
子宫内膜异位症的诊断不会对 c-IVF 的表现产生负面影响;因此,除非还存在男性因素,否则可以有效地在受影响的女性中使用 c-IVF。这个问题对帮助操作人员做出授精技术决策具有临床意义。